NO975561L - Kalsiumkanalantagonister - Google Patents
KalsiumkanalantagonisterInfo
- Publication number
- NO975561L NO975561L NO975561A NO975561A NO975561L NO 975561 L NO975561 L NO 975561L NO 975561 A NO975561 A NO 975561A NO 975561 A NO975561 A NO 975561A NO 975561 L NO975561 L NO 975561L
- Authority
- NO
- Norway
- Prior art keywords
- calcium channel
- channel antagonists
- alkyl
- phenyl
- rog
- Prior art date
Links
- 229940127291 Calcium channel antagonist Drugs 0.000 title 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 108090000312 Calcium Channels Proteins 0.000 abstract 1
- 102000003922 Calcium Channels Human genes 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 hexamethyleneimino Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/485,406 US5840747A (en) | 1995-06-07 | 1995-06-07 | Calcium channel antagonists |
| PCT/US1996/009162 WO1996040134A1 (en) | 1995-06-07 | 1996-06-04 | Calcium channel antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO975561D0 NO975561D0 (no) | 1997-12-02 |
| NO975561L true NO975561L (no) | 1997-12-02 |
Family
ID=23928032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO975561A NO975561L (no) | 1995-06-07 | 1997-12-02 | Kalsiumkanalantagonister |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5840747A (pl) |
| EP (1) | EP0831822B1 (pl) |
| JP (1) | JPH11506788A (pl) |
| KR (1) | KR19990022499A (pl) |
| CN (1) | CN1193274A (pl) |
| AT (1) | ATE252902T1 (pl) |
| AU (1) | AU714403B2 (pl) |
| CA (1) | CA2223711A1 (pl) |
| CZ (1) | CZ288546B6 (pl) |
| DE (1) | DE69630523T2 (pl) |
| EA (1) | EA001928B1 (pl) |
| ES (1) | ES2210373T3 (pl) |
| HU (1) | HUP9900916A3 (pl) |
| IL (1) | IL122459A (pl) |
| MX (1) | MX9709468A (pl) |
| NO (1) | NO975561L (pl) |
| NZ (1) | NZ310178A (pl) |
| PL (1) | PL183998B1 (pl) |
| RO (1) | RO116344B1 (pl) |
| UA (1) | UA43895C2 (pl) |
| WO (1) | WO1996040134A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008232A (en) * | 1997-08-20 | 1999-12-28 | Eli Lilly And Company | Methods for preventing headaches |
| WO2001026651A2 (en) * | 1999-10-14 | 2001-04-19 | Endorecherche, Inc. | Selective estrogen receptor modulators in the treatment or reduction of the risk of acquiring hypertension, cardiovascular diseases, and insulin resistance |
| EP1113007A1 (en) | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US5447941A (en) * | 1993-12-21 | 1995-09-05 | Eli Lilly And Company | Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes |
| US5441965A (en) * | 1993-12-21 | 1995-08-15 | Eli Lilly And Company | Methods of inhibiting thrombin |
| US6562862B1 (en) * | 1994-10-20 | 2003-05-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
| US5532254A (en) * | 1995-06-07 | 1996-07-02 | Eli Lilly And Company | Modulation of calcium channels using benzothiophenes |
-
1995
- 1995-06-07 US US08/485,406 patent/US5840747A/en not_active Expired - Fee Related
-
1996
- 1996-04-06 UA UA97125831A patent/UA43895C2/uk unknown
- 1996-06-04 CA CA002223711A patent/CA2223711A1/en not_active Abandoned
- 1996-06-04 DE DE69630523T patent/DE69630523T2/de not_active Expired - Fee Related
- 1996-06-04 EP EP96918210A patent/EP0831822B1/en not_active Expired - Lifetime
- 1996-06-04 JP JP9501551A patent/JPH11506788A/ja active Pending
- 1996-06-04 AT AT96918210T patent/ATE252902T1/de not_active IP Right Cessation
- 1996-06-04 AU AU60919/96A patent/AU714403B2/en not_active Ceased
- 1996-06-04 NZ NZ310178A patent/NZ310178A/en unknown
- 1996-06-04 MX MX9709468A patent/MX9709468A/es not_active IP Right Cessation
- 1996-06-04 WO PCT/US1996/009162 patent/WO1996040134A1/en not_active Application Discontinuation
- 1996-06-04 IL IL12245996A patent/IL122459A/en not_active IP Right Cessation
- 1996-06-04 ES ES96918210T patent/ES2210373T3/es not_active Expired - Lifetime
- 1996-06-04 HU HU9900916A patent/HUP9900916A3/hu unknown
- 1996-06-04 KR KR1019970708980A patent/KR19990022499A/ko not_active Application Discontinuation
- 1996-06-04 RO RO97-02247A patent/RO116344B1/ro unknown
- 1996-06-04 PL PL96324086A patent/PL183998B1/pl unknown
- 1996-06-04 EA EA199800033A patent/EA001928B1/ru not_active IP Right Cessation
- 1996-06-04 CZ CZ19973828A patent/CZ288546B6/cs not_active IP Right Cessation
- 1996-06-04 CN CN96195976A patent/CN1193274A/zh active Pending
-
1997
- 1997-12-02 NO NO975561A patent/NO975561L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO975561D0 (no) | 1997-12-02 |
| US5840747A (en) | 1998-11-24 |
| ATE252902T1 (de) | 2003-11-15 |
| CN1193274A (zh) | 1998-09-16 |
| AU6091996A (en) | 1996-12-30 |
| RO116344B1 (ro) | 2001-01-30 |
| EP0831822A4 (en) | 2001-12-19 |
| DE69630523T2 (de) | 2004-08-12 |
| HUP9900916A2 (hu) | 1999-09-28 |
| EA199800033A1 (ru) | 1998-06-25 |
| DE69630523D1 (de) | 2003-12-04 |
| CZ288546B6 (cs) | 2001-07-11 |
| AU714403B2 (en) | 2000-01-06 |
| ES2210373T3 (es) | 2004-07-01 |
| PL183998B1 (pl) | 2002-08-30 |
| IL122459A0 (en) | 1998-06-15 |
| EP0831822A1 (en) | 1998-04-01 |
| PL324086A1 (en) | 1998-05-11 |
| NZ310178A (en) | 2000-06-23 |
| EA001928B1 (ru) | 2001-10-22 |
| CZ382897A3 (cs) | 1999-01-13 |
| EP0831822B1 (en) | 2003-10-29 |
| WO1996040134A1 (en) | 1996-12-19 |
| MX9709468A (es) | 1998-04-30 |
| IL122459A (en) | 2001-05-20 |
| HUP9900916A3 (en) | 1999-11-29 |
| CA2223711A1 (en) | 1996-12-19 |
| UA43895C2 (uk) | 2002-01-15 |
| KR19990022499A (ko) | 1999-03-25 |
| JPH11506788A (ja) | 1999-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO973635L (no) | Fremgangsmåte for hemming av celle-celle adhesjon | |
| DK0652005T3 (da) | Fremgangsmåder til inhibering af endometriose | |
| NO944927L (no) | Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom | |
| DK0651999T3 (da) | Fremgangsmåder til inhibering af livmoderfibrose | |
| MX9701325A (es) | Metodos para inhibir la mucositis ulcerativa. | |
| DK0659417T3 (da) | Fremgangsmåder til inhibering af dysfunktionel blødning fra livmoderen | |
| MX9701329A (es) | Metodos para la inhibicion de la replicacion viral. | |
| NO944926L (no) | Fremgangsmåter for å inhibere myeloperoksidaseaktivitet | |
| NO944933L (no) | Fremgangsmåte for å inhibere sykdomstilstander i brystet | |
| NO975580L (no) | Fremgangsmåte for å inhibere melanom | |
| NO944931L (no) | Anvendelse av 2-fenyl-3-aroylbenzotiofener for inhibering av tidlig seksuell modenhet | |
| NO970786L (no) | Fremgangsmåte for hemming av benprotesedegradering | |
| NO975738L (no) | Modulering av kalsiumkanaler | |
| NO973367L (no) | Fremgangsmåte for å inhibere miljömessige östrogen | |
| NO975561L (no) | Kalsiumkanalantagonister | |
| NO981578L (no) | FremgangsmÕte for hemming av plasminogenaktivatorhemmer I | |
| NO973609L (no) | Fremgangsmåte for å inhibere effektene av IL-6 | |
| NO971029L (no) | Fremgangsmåter for hemming av endometriale metoser | |
| NO20000750L (no) | FremgangsmÕte for Õ redusere blodplatetall | |
| NO973103L (no) | Fremgangsmåte for inhibering av veksthormoneffekter | |
| NO944909L (no) | Fremgangsmåter for inhibering av mannlig infertilitet | |
| DK0771201T3 (da) | Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi | |
| NO983452L (no) | FremgangsmÕter for Õ hemme muskuloaponeurotisk fibromatose (desmoide tumorer) | |
| MX9701331A (es) | Metodos para mantener los dientes y los huesos bucales. | |
| MX9705697A (es) | Metodos para reducir los niveles de calcio del suero. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |